chr12-57715785-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006812.4(OS9):āc.605T>Cā(p.Ile202Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000484 in 1,612,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006812.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OS9 | NM_006812.4 | c.605T>C | p.Ile202Thr | missense_variant | 6/15 | ENST00000315970.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OS9 | ENST00000315970.12 | c.605T>C | p.Ile202Thr | missense_variant | 6/15 | 1 | NM_006812.4 | P4 | |
ENST00000549477.1 | n.534+5192A>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000761 AC: 19AN: 249612Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134890
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1459724Hom.: 0 Cov.: 32 AF XY: 0.0000152 AC XY: 11AN XY: 726012
GnomAD4 genome AF: 0.000263 AC: 40AN: 152356Hom.: 0 Cov.: 32 AF XY: 0.000268 AC XY: 20AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 09, 2021 | The c.605T>C (p.I202T) alteration is located in exon 6 (coding exon 6) of the OS9 gene. This alteration results from a T to C substitution at nucleotide position 605, causing the isoleucine (I) at amino acid position 202 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at